Liver cancer drug market size was valued at US$ 3.8 billion in 2024 and is projected to hit the market valuation of US$ 17.2 billion by 2033 at a CAGR of 18.2% during the forecast period 2025–2033. A ...

Morgan Stanley (MS) has issued a less optimistic outlook on the performance of the shares of American pharmaceutical giant ...

Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. Keep ...

Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you ...

The US Food and Drug Administration intends to put a “black box” warning on Covid-19 vaccines, according to two people ...

FDA weighs black box warning for COVID-19 vaccines, signaling a major shift in safety labeling and regulatory approach for these shots.

The UK-US deal does not resolve every challenge – no single agreement could. But it marks a meaningful step toward restoring ...

Fresh from a blockbuster rights deal with drugs giant Pfizer earlier this year, 3SBio has announced a subsidiary spin-off and ...

Company addresses FDA requests regarding formulation excipient – Global site start-up activities continue, with first-patient-in for ...

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...